Synergistic Infusion System
Legal Citation
Summary of the Inventive Concept
The Synergistic Infusion System integrates the High Flow, Needleless Connector with AI, IoT, blockchain, and novel materials to create a more secure, efficient, and intelligent infusion therapy system.
Background and Problem Solved
The original High Flow, Needleless Connector patent addressed the need for safe connections in infusion therapies, but limitations in contamination detection, real-time monitoring, and device tracking persisted. The Synergistic Infusion System solves these problems by combining the connector with advanced technologies.
Detailed Description of the Inventive Concept
The system comprises an injection port assembly (claim 1) integrated with an AI-powered sensor to detect contamination, an IoT-enabled device for real-time fluid flow rate monitoring, a blockchain-based tracking system for device usage and maintenance, and a novel self-healing, antimicrobial material composition. The machine learning algorithm predicts and prevents adverse reactions to infused medications, ensuring a safer and more efficient infusion therapy experience.
Novelty and Inventive Step
The integration of the High Flow, Needleless Connector with AI, IoT, blockchain, and novel materials creates a synergistic effect, providing a more comprehensive and intelligent infusion therapy system that is not obvious from the original patent.
Alternative Embodiments and Variations
Alternative embodiments may include integrating the injection port assembly with other advanced technologies, such as augmented reality or nanotechnology, to further enhance the infusion therapy experience. Variations may include adapting the system for use in different medical settings or for specific patient populations.
Potential Commercial Applications and Market
The Synergistic Infusion System has significant commercial potential in the healthcare industry, particularly in hospitals, clinics, and home care settings, where it can improve patient safety, reduce costs, and enhance the overall quality of care.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61M39/146 |
| A | A61 | A61M39/26 |
| A | A61 | A61M2039/1083 |
| A | A61 | A61M2039/1088 |
| A | A61 | A61M2039/267 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device design, specifically intravenous and injection port systems, with expertise in fluid transfer technologies, medical device integration, and biomedical engineering
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer or medical device designer with advanced degree, 5-7 years experience in medical device integration, familiar with emerging technologies in healthcare, understanding of fluid transfer mechanisms, sensor integration, and material science applications
Obviousness Rationale
A PHOSITA would recognize that integrating advanced technologies like AI, IoT, and blockchain into existing medical device architectures represents a predictable extension of current medical device innovation trends. The core injection port assembly remains fundamentally consistent with the source patent, with added technological layers that represent standard design evolution in medical device development. The proposed variations represent incremental improvements using known technological integration techniques.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,752 |
|---|---|
| Title | High flow, needleless connector |
| Assignee(s) | RyMed Technologies, LLC |